FORT WORTH, Texas, Jan. 21 ... has granted Fast Track designation to NPI-001 (N-acetylcysteine amide) tablets, Nacuity’s proprietary investigational therapy for the treatment of patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback